Evidence map›Paper›PMID 41609269›Full record

ArticleJACC. Case reports2026

Iatrogenic Hepatocellular Adenoma in Relation to an Unusual Complication of Cardiac Surgery.

Luis E Echeverria, Omar Nicolas Ferro-Peñuela, Angie Yarlady Serrano-García, Laura V Arciniegas-Landinez

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luis E EcheverriaHeart Failure and Cardiac Transplant Division, Fundación Cardiovascular de Colombia, Universidad de Santander, Santander, Colombia; Department of Medicine, Universidad de Santander, Santander, Colombia. Electronic address: luisedo10@gmail.com.
Omar Nicolas Ferro-PeñuelaDepartment of Clinical Trials, Fundación Cardiovascular de Colombia, Santander, Colombia.
Angie Yarlady Serrano-GarcíaHeart Failure and Cardiac Transplant Division, Fundación Cardiovascular de Colombia, Universidad de Santander, Santander, Colombia.
Laura V Arciniegas-LandinezMedical School, Universidad Industrial de Santander, Santander, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInferior vena cava (IVC) obstruction is a rare but serious complication after atrial septal defect (ASD) repair. CASE SUMMARY: A 50-year-old woman with prior ASD closure presented for liver transplant evaluation due to cirrhosis and a suspected hepatocellular adenoma. Examination revealed congestive hepatopathy and dyspnea (NYHA II). Imaging identified IVC obstruction from Eustachian valve entrapment and thrombus at the cavoatrial junction. She underwent successful IVC recanalization and thrombectomy, with resolution of symptoms, prompting suspension of transplant listing. DISCUSSION: IVC obstruction after ASD repair is exceedingly rare but can mimic liver disease and precipitate Budd-Chiari syndrome. Unlike previously reported cases, our patient uniquely demonstrated the coexistence of cirrhosis and an HNF1A-inactivated hepatocellular adenoma, a combination not described before in this setting. This case underscores the need to consider cardiac causes in unexplained hepatopathy, especially post-ASD repair. TAKE-HOME MESSAGES: IVC obstruction should be suspected in post-ASD repair patients with hepatopathy. Early recognition allows curative intervention and avoids unnecessary transplantation.

Indexed as

adenomaBudd-Chiari syndromeechocardiographyliver cellliver transplantation

Identifiers

PMID41609269
PMCPMC12882686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.